Indication
Intraventricular Hemorrhage
3 clinical trials
3 products
Clinical trial
A Phase 2b, Multicenter, Randomized, Open-label, Two-Arm Study to Evaluate the Clinical Efficacy and Safety of OHB-607 in Preventing Chronic Lung Disease in Extremely Premature Infants Compared to Standard Neonatal CareStatus: Active (not recruiting), Estimated PCD: 2026-08-28
Product
OHB-607Clinical trial
Safety of Combined Therapy With Erythropoietin and Melatonin for Very Preterm Infants With Intraventricular Hemorrhage (SCEMPI)Status: Recruiting, Estimated PCD: 2027-09-30
Product
MLT+EPOClinical trial
The Efect of Azithromicyn on Bronchopulmonary Displasia in Extremely Preterm and Very Preterm InfantStatus: Completed, Estimated PCD: 2022-03-01
Product
Azithromycin